Foresite Capital Management Iv, LLC Voyager Therapeutics, Inc. Transaction History

Foresite Capital Management Iv, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$7.15 - $12.28 $3.69 Million - $6.35 Million	-516,751 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$6.8 - $14.66 $2.13 Million - $4.6 Million	-313,814 Reduced 37.78%	516,751 $4.73 Million
Q3 2019 Nov 13, 2019	BUY	$16.31 - $28.29 $4.79 Million - $8.31 Million	293,794 Added 54.73%	830,565 $14.3 Million
Q2 2019 Aug 13, 2019	BUY	$19.18 - $27.88 $6.88 Million - $10 Million	358,967 Added 201.89%	536,771 $14.6 Million
Q1 2019 May 14, 2019	BUY	$8.0 - $19.66 $1.42 Million - $3.5 Million	177,804 New	177,804 $3.4 Million

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $219M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.